adenosine diphosphate has been researched along with Alzheimer Disease in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (22.73) | 18.2507 |
| 2000's | 3 (13.64) | 29.6817 |
| 2010's | 11 (50.00) | 24.3611 |
| 2020's | 3 (13.64) | 2.80 |
| Authors | Studies |
|---|---|
| Blurton-Jones, M; Cahalan, MD; Chadarevian, JP; Cho, H; Gandhi, S; Granzotto, A; Jairaman, A; Kang, YJ; McQuade, A; Othy, S; Parker, I; Sensi, SL; Smith, I | 1 |
| Ardekani, BA; Beiser, A; Berger, JS; Betensky, RA; Bubu, OM; Convit, A; Do, N; Fillmore, NR; Johnson, AD; Kovbasyuk, Z; Osorio, RS; Parekh, A; Pomara, N; Ramos-Cejudo, J; Salinas, J; Seshadri, S; Wisniewski, TM; Zheng, C | 1 |
| Archa Rajagopal, J; Chase Barton, C; Davis Sanders, O; Lopez, K; Lopez, O; Malik, F; Rajagopal, L | 1 |
| Blank, N; Breithausen, B; Delekate, A; Fuhrmann, M; Halle, A; Hansen, JN; Henneberger, C; Keller, A; Keppler, K; Peter, J; Petzold, GC; Plescher, M; Poll, S; Reichenbach, N; Schulte, T | 1 |
| Donner, L; Elvers, M; Gertzen, CGW; Gohlke, H; Gremer, L; Willbold, D; Ziehm, T | 1 |
| Amadoro, G; Atlante, A; Bobba, A; Calissano, P; Petragallo, VA | 1 |
| Canobbio, I; Catricalà, S; Consonni, A; Di Pasqua, LG; Guidetti, G; Manganaro, D; Torti, M | 1 |
| Coskuner, O; Murray, IV | 1 |
| Canobbio, I; Guidetti, GF; Manganaro, D; Oliviero, B; Pula, G; Torti, M; Vara, D | 1 |
| Bamburg, JR; Bernstein, BW | 1 |
| Barbosa, RM; Laranjinha, J; Ledo, A; Lourenço, CF | 1 |
| Barbati, C; Malorni, W; Masella, R; Ortona, E; Rosano, G; Scazzocchio, B; Vacirca, D | 1 |
| Amadoro, G; Atlante, A; Bussani, R; Calissano, P; Capsoni, S; Corsetti, V; Florenzano, F; Mercanti, D | 1 |
| Akolkar, H; Mandal, PK; Tripathi, M | 1 |
| Grundke-Iqbal, I; Iqbal, K; Rahman, A | 1 |
| Dmitriev, LF | 1 |
| Delwaide, PJ | 1 |
| Beyreuther, K; Cappai, R; Galatis, D; Henry, A; Hesse, L; Li, QX; Masters, CL; Multhaup, G | 1 |
| Hoyer, S; Lannert, H | 1 |
| Dave, KR; Katyare, SS; Swegert, CV | 1 |
| Chambers, J; Emson, P; Iritani, S; Moore, D | 1 |
| Liu, S; Sylvester, DM | 1 |
3 review(s) available for adenosine diphosphate and Alzheimer Disease
| Article | Year |
|---|---|
Does oxidative DNA damage trigger histotoxic hypoxia via PARP1/AMP-driven mitochondrial ADP depletion-induced ATP synthase inhibition in Alzheimer's disease?
Topics: Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Alzheimer Disease; DNA Damage; Humans; Hypoxia; Mitochondrial Proton-Translocating ATPases; NAD; Oxidative Stress; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerases | 2022 |
Actin dynamics and cofilin-actin rods in alzheimer disease.
Topics: Actin Cytoskeleton; Actin Depolymerizing Factors; Actins; Adenosine Diphosphate; Alzheimer Disease; Amyloid beta-Peptides; Animals; Biological Transport, Active; Humans; Protein Multimerization | 2016 |
Shortage of lipid-radical cycles in membranes as a possible prime cause of energetic failure in aging and Alzheimer disease.
Topics: Adenosine Diphosphate; Aging; Aldehydes; alpha-Tocopherol; Alzheimer Disease; Animals; Antioxidants; Apoptosis; Cell Membrane; Energy Metabolism; Fatty Acids, Unsaturated; Humans; Lipid Peroxidation; Mitochondria; Mitochondrial ADP, ATP Translocases; Molecular Structure; NAD; Oxidation-Reduction; Reactive Oxygen Species | 2007 |
19 other study(ies) available for adenosine diphosphate and Alzheimer Disease
| Article | Year |
|---|---|
TREM2 regulates purinergic receptor-mediated calcium signaling and motility in human iPSC-derived microglia.
Topics: Adenosine Diphosphate; Alzheimer Disease; Calcium; Calcium Signaling; Humans; Induced Pluripotent Stem Cells; Membrane Glycoproteins; Microglia; Receptors, Immunologic; Receptors, Purinergic | 2022 |
Platelet Function Is Associated With Dementia Risk in the Framingham Heart Study.
Topics: Adenosine Diphosphate; Alzheimer Disease; Female; Humans; Longitudinal Studies; Male; Platelet Aggregation; Platelet Function Tests; Risk Factors | 2022 |
P2Y1 receptor blockade normalizes network dysfunction and cognition in an Alzheimer's disease model.
Topics: Adenosine Diphosphate; Alzheimer Disease; Animals; Astrocytes; Cognition; Disease Models, Animal; Hippocampus; Humans; Memory; Mice, Transgenic; Nerve Net; Neurons; Plaque, Amyloid; Purinergic P2Y Receptor Antagonists; Receptors, Purinergic P2Y1; Signal Transduction; Synapses | 2018 |
Relevance of N-terminal residues for amyloid-β binding to platelet integrin α
Topics: Adenosine Diphosphate; Alzheimer Disease; Amyloid; Amyloid beta-Peptides; Blood Platelets; Cerebral Amyloid Angiopathy; Clusterin; Humans; Platelet Glycoprotein GPIIb-IIIa Complex; Signal Transduction | 2018 |
Dissecting the molecular mechanism by which NH2htau and Aβ1-42 peptides impair mitochondrial ANT-1 in Alzheimer disease.
Topics: Adenine Nucleotide Translocator 1; Adenosine Diphosphate; Adenosine Triphosphate; Alzheimer Disease; Amyloid beta-Peptides; Animals; Cells, Cultured; Cerebellum; Cytoplasmic Granules; Energy Metabolism; Enzyme Inhibitors; Mersalyl; Mitochondria; Models, Neurological; Oxygen Consumption; Peptide Fragments; Polarography; Rats; Rats, Wistar; Reactive Oxygen Species; Superoxides; tau Proteins | 2013 |
Immobilized amyloid Aβ peptides support platelet adhesion and activation.
Topics: Adenosine Diphosphate; Alzheimer Disease; Amyloid beta-Peptides; Blood Vessels; Cell Adhesion; Cell Membrane; Cerebrovascular Disorders; Collagen; Humans; Immobilized Proteins; Metalloproteases; Phosphatidylinositol 3-Kinases; Platelet Activation; Platelet Adhesiveness; Protein Kinase C; Thrombosis | 2013 |
Adenosine triphosphate (ATP) reduces amyloid-β protein misfolding in vitro.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Blotting, Western; Female; Humans; Magnesium; Male; Molecular Dynamics Simulation; Peptide Fragments; Protein Folding; Protein Structure, Secondary | 2014 |
Amyloid β-peptide-dependent activation of human platelets: essential role for Ca2+ and ADP in aggregation and thrombus formation.
Topics: Adenosine Diphosphate; Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Blood Platelets; Calcium; Humans; Peptide Fragments; Platelet Activation; Platelet Aggregation; Signal Transduction | 2014 |
Neurovascular uncoupling in the triple transgenic model of Alzheimer's disease: Impaired cerebral blood flow response to neuronal-derived nitric oxide signaling.
Topics: Adenosine Diphosphate; Age Factors; Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Body Weight; Cerebrovascular Circulation; Disease Models, Animal; Excitatory Amino Acid Agonists; Glutamic Acid; Humans; Maze Learning; Mice; Mice, Inbred C57BL; Mice, Transgenic; Mutation; Neurovascular Coupling; Nitric Oxide; Nitric Oxide Synthase Type I; Presenilin-1; Signal Transduction; tau Proteins | 2017 |
Anti-ATP synthase autoantibodies from patients with Alzheimer's disease reduce extracellular HDL level.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Aged; Aged, 80 and over; Alzheimer Disease; Antibody Specificity; Apoptosis; Autoantibodies; Cell Line; Cholesterol, HDL; Enzyme Inhibitors; Extracellular Space; Female; Fluorescent Dyes; Humans; Male; Middle Aged; Proton-Translocating ATPases; Stilbenes | 2011 |
Interaction between NH(2)-tau fragment and Aβ in Alzheimer's disease mitochondria contributes to the synaptic deterioration.
Topics: Adenine Nucleotide Translocator 1; Adenosine Diphosphate; Adenosine Triphosphate; Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Analysis of Variance; Animals; Animals, Newborn; Apoptosis; Brain; Cells, Cultured; Cerebellum; Cyclophilins; Disks Large Homolog 4 Protein; Enzyme Inhibitors; Female; Humans; Immunoprecipitation; Intracellular Signaling Peptides and Proteins; Lewy Body Disease; Male; Membrane Proteins; Middle Aged; Mitochondria; Neuroblastoma; Neurons; Parkinson Disease; Peptide Fragments; Rats; Rats, Wistar; Receptors, AMPA; Staurosporine; Subcellular Fractions; Synapses; Synaptosomes; tau Proteins | 2012 |
Mapping of hippocampal pH and neurochemicals from in vivo multi-voxel 31P study in healthy normal young male/female, mild cognitive impairment, and Alzheimer's disease.
Topics: Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Aged; Alzheimer Disease; Cognitive Dysfunction; Creatine Kinase, BB Form; Data Interpretation, Statistical; Female; Functional Laterality; Hippocampus; Humans; Hydrogen-Ion Concentration; Image Processing, Computer-Assisted; Lipid Peroxidation; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Phosphorus Isotopes; Reference Values | 2012 |
Phosphothreonine-212 of Alzheimer abnormally hyperphosphorylated tau is a preferred substrate of protein phosphatase-1.
Topics: Adenosine Diphosphate; Alzheimer Disease; Aniline Compounds; Blotting, Western; Brain Chemistry; Calcineurin; Calmodulin; Chromatography, Agarose; Chromatography, DEAE-Cellulose; Chromatography, Gel; Enzyme Inhibitors; Humans; Okadaic Acid; Organophosphorus Compounds; Phosphoprotein Phosphatases; Phosphorylation; Phosphothreonine; Polylysine; Protein Phosphatase 1; Recombinant Proteins; Substrate Specificity; tau Proteins; Triazines | 2005 |
[NO. and the central nervous system].
Topics: Adenosine Diphosphate; Alzheimer Disease; Brain Chemistry; Cell Communication; Cyclic GMP; Humans; Huntington Disease; Neurotransmitter Agents; Nitric Oxide | 1995 |
Inhibition of platelet activation by the Alzheimer's disease amyloid precursor protein.
Topics: Adenosine Diphosphate; Alzheimer Disease; Amyloid beta-Protein Precursor; Arachidonic Acid; Cell Culture Techniques; Dinoprostone; Dose-Response Relationship, Drug; Epinephrine; Humans; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Recombinant Proteins; Structure-Activity Relationship; Thrombin; Thromboxane B2 | 1998 |
Intracerebroventricular administration of streptozotocin causes long-term diminutions in learning and memory abilities and in cerebral energy metabolism in adult rats.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Alzheimer Disease; Animals; Avoidance Learning; Behavior, Animal; Blood Glucose; Brain; Disease Models, Animal; Energy Metabolism; Habituation, Psychophysiologic; Male; Memory; Practice, Psychological; Rats; Rats, Wistar; Receptor, Insulin; Statistics, Nonparametric; Streptozocin | 1998 |
Effect of aluminium-induced Alzheimer like condition on oxidative energy metabolism in rat liver, brain and heart mitochondria.
Topics: Adenosine Diphosphate; Adenosine Triphosphatases; Aging; Aluminum Chloride; Aluminum Compounds; Alzheimer Disease; Animals; Body Temperature; Brain; Chlorides; Disease Models, Animal; Energy Metabolism; Glutamic Acid; Male; Membrane Fluidity; Mitochondria, Heart; Mitochondria, Liver; Oxidative Phosphorylation; Rats | 1999 |
Immunohistochemical localization of the P2Y1 purinergic receptor in Alzheimer's disease.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Aged; Alzheimer Disease; Brain; Brain Chemistry; Entorhinal Cortex; Female; Hippocampus; Humans; Immunoblotting; Immunohistochemistry; Male; Middle Aged; Neurofibrillary Tangles; Plaque, Amyloid; Pyramidal Tracts; Receptors, Purinergic P2; Receptors, Purinergic P2Y1; tau Proteins | 2000 |
The inhibitory effect of 9-amino-1,2,3,4-tetrahydroacridine (THA) on platelet function.
Topics: Adenosine Diphosphate; Aequorin; Alzheimer Disease; Blood Platelets; Calcimycin; Calcium; Collagen; Humans; Phorbol Esters; Platelet Aggregation; Platelet Aggregation Inhibitors; Tacrine | 1992 |